08:29 AM EDT, 06/20/2024 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) , which operates in the commercial dermatology market, said on Thursday that it has agreed to buy all of the non-real estate business assets of Occy Laboratory, a Laval-based manufacturer and distributor of high-quality dermo-cosmetic products.

The acquired assets include Occy's manufacturing equipment, inventory, customer network, and intellectual property.

Crescita will continue the commercial activities carried out by Occy before closing while integrating the assets into its operations in the coming months.

Crescita will provide financial information following the closing of the deal.